Magmaris

Vascular Intervention // Coronary
Resorbable Magnesium Scaffold (RMS)

Magmaris

 

 



     Compelling safety data

     Fast Magnesium resorption time

     Better deliverability

 

 

 

 


Why Magnesium?

 

 

 

 


Magnesium alloy: Favorable mechanical properties of a robust Magnesium backbone


Robust Magnesium backbone

 

 


The mechanical strength of Magnesium is superior to polymers like PLLA.1






Stable recoil


Magmaris has a 38% lower recoil after 1 hour.2



*Absorb, Abbott



Strong radial resistance


No significant diameter change under increasing physiological pressure.3






Rounded edges and smooth surface


 

 

The electropolished rounded edges and smooth surface of the Magmaris scaffold generate less resistance during delivery of the scaffold to the lesion.





Compelling safety data

 

 

 

 


Confidence through evidence





*Target Lesion Failure. Composite of cardiac and unknown death, target vessel myocardial infarction, clinically driven target lesion revascularization and CABG.
** Patient underwent MIDCAB with subsequent DAPT interruption 5 days after the procedure.







Fast resorption time

 

 

 

 


~95% of Magnesium resorbed at 12 months7









A more deliverable scaffold

 

 

 

 


More than 70% of physicians who have used Magmaris RMS in clinical practice have rated the device to be better than a polymeric scaffold.9*



Better lesion crossing

 

 


Up to 40% lower lesion entry and crossing force.10







Better trackability in tortuous anatomy


42% less peak force.11











Better pushability


73% more force transmitted from hub to tip.12





* Absorb, Abbott
** BioFreedom, Biosensors


 

 


 

 

Magmaris


Indicated for de novo coronary artery lesions.*

Technical Data

Scaffold
Scaffold material Proprietary Magnesium alloy
Markers Two tantalum markers at each end
Active coating BIOlute bioabsorbable Poly-L-Lactide (PLLA) eluting a limus drug
Drug dose 1.4 μg/mm2
Strut thickness/width 150 μm/150 μm
Maximum expandable diameter Nominal Diameter +0.6 mm
Delivery System
Catheter type Rapid exchange
Recommended guide catheter 6F (min. I.D. 0.070")
Crossing profile 1.5 mm
Guide wire diameter 0.014"
Usable catheter length 140 cm
Balloon material Semi-rystalline polymer
Coating (distal shaft) Dual coated
Marker bands Two swaged platinum-iridium markers
Proximal shaft diameter 2.0F
Distal shaft diameter 2.9F
Nominal pressure (NP) 10 atm
Rated burst pressure (RBP) 16 atm

Compliance Chart

Balloon Diameter x Length (mm)
Nominal Pressure atm8 10 10
(NP) ø (mm) 3.00 3.54
Rated Burst Pressure atm8 16 16
(RBP) ø (mm) 3.29 3.82

Ordering Information

3.00 412526 412527 412528
3.50 412529 412530 412531

Contact

contact
Country/Region
16 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Image

VASCULAR INTERVENTION

Coronary Resorbable Magnesium Scaffold


1 BIOTRONIK data on file;

2 BIOTRONIK data on file;

3 BIOTRONIK data on file;

4 Waksman R. Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month follow-up- BIOSOLVE-II and BIOSOLVE-III. Presented at tct 2017; October 31, 2017; Denver, USA;

5 Haude M, Ince H, Kische S, et al. Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III. EuroIntervention. 2017;13(4): 432-439;

6 Haude M, Erbel R, Erne, et al. Safety and performance of the Drug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. EuroIntervention. 2016; 12(2): e160-6;

7 BIOTRONIK data on file;

8 BIOSOLVE-II case, GER443-001. Courtesy of M. Haude, Lukaskrankenhaus Neuss, Germany 2015.

Absorb is a registered trademark of Abbott Laboratories; BioFreedom is a registered trademark of Biosensors Europe.

*Indication as per IFU.